161 related articles for article (PubMed ID: 18977724)
1. Statements from the 15th International Symposium on HIV and Emerging Infectious Diseases (ISHEID), Toulon, France, May 28-30, 2008.
Haubrich R; Soriano V; Lafeuillade A
HIV Clin Trials; 2008; 9(5):348-65. PubMed ID: 18977724
[TBL] [Abstract][Full Text] [Related]
2. Influence of viral hepatitis on HIV infection.
Rockstroh JK
J Hepatol; 2006; 44(1 Suppl):S25-7. PubMed ID: 16338020
[TBL] [Abstract][Full Text] [Related]
3. HIV and hepatitis C co-infection: the role of HAART in HIV/hepatitis C virus management.
Jones M; Núñez M
Curr Opin HIV AIDS; 2011 Nov; 6(6):546-52. PubMed ID: 22001896
[TBL] [Abstract][Full Text] [Related]
4. Management of chronic hepatitis B and C in HIV-coinfected patients.
Soriano V; Barreiro P; Nuñez M
J Antimicrob Chemother; 2006 May; 57(5):815-8. PubMed ID: 16556638
[TBL] [Abstract][Full Text] [Related]
5. Interaction of hepatitis B and C viruses in patients infected with HIV.
Rong-Rong Y; Xi-En G; Shi-Cheng G; Yong-Xi Z
J Acquir Immune Defic Syndr; 2008 Aug; 48(4):505-6. PubMed ID: 18614932
[No Abstract] [Full Text] [Related]
6. Hepatitis B virus infection: co-infection with hepatitis C virus, hepatitis D virus, and human immunodeficiency virus.
Shukla NB; Poles MA
Clin Liver Dis; 2004 May; 8(2):445-60, viii. PubMed ID: 15481349
[TBL] [Abstract][Full Text] [Related]
7. IFN-alpha: therapeutic options in HIV and HIV/HCV, HIV/HBV dual infection.
Jablonowski H
Infection; 2003 Mar; 31(2):131-3. PubMed ID: 12749300
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).
Diop-Ndiaye H; Touré-Kane C; Etard JF; Lô G; Diaw P; Ngom-Gueye NF; Gueye PM; Ba-Fall K; Ndiaye I; Sow PS; Delaporte E; Mboup S
J Med Virol; 2008 Aug; 80(8):1332-6. PubMed ID: 18551596
[TBL] [Abstract][Full Text] [Related]
9. HIV and hepatitis virus resistance to antivirals: review of data from the XIX International HIV and Hepatitis Virus Drug Resistance Workshop and curative strategies.
Mascolini M; Mellors JW; Richman DD; Boucher CA; Larder BA
Antivir Ther; 2011; 16(2):263-86. PubMed ID: 21447877
[TBL] [Abstract][Full Text] [Related]
10. Interference of replication between hepatitis B and C viruses in patients infected with HIV.
Yang RR; Gui X; Chen XY; Zhu Y
J Med Virol; 2011 Jul; 83(7):1159-64. PubMed ID: 21567419
[TBL] [Abstract][Full Text] [Related]
11. Temporal Trends in the Epidemiology of HIV in Turkey.
Erdinc FS; Dokuzoguz B; Unal S; Komur S; Inkaya AC; Inan D; Karaoglan I; Deveci A; Celen MK; Kose S; Erben N; Senturk GC; Heper Y; Kutlu SS; Hatipoglu CA; Sumer S; Kandemir B; Sirmatel F; Bayindir Y; Yilmaz E; Ersoy Y; Kazak E; Yildirmak MT; Kayaaslan B; Ozden K; Sener A; Kara A; Gunal O; Birengel S; Akbulut A; Yetkin F; Cuvalci NO; Sargin F; Pullukcu H; Gokengin D; Multicentric Hiv Study Group
Curr HIV Res; 2020; 18(4):258-266. PubMed ID: 32342820
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of HIV-HCV and HBV-HCV co-infection].
Jmelnitzky AC; Jorge O; Manero E
Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S46-8. PubMed ID: 20214301
[No Abstract] [Full Text] [Related]
13. The impact of human immunodeficiency virus on viral hepatitis.
Mallet V; Vallet-Pichard A; Pol S
Liver Int; 2011 Jan; 31 Suppl 1():135-9. PubMed ID: 21205151
[TBL] [Abstract][Full Text] [Related]
14. [The influence of human immunodeficiency virus co-infection with hepatitis C virus and hepatitis B virus on the efficacy of high active anti-retroviral therapy].
Li XF; Kan QC; He Y; Yu ZJ; Li ZQ; Liang HX
Zhonghua Nei Ke Za Zhi; 2010 Nov; 49(11):951-4. PubMed ID: 21211210
[TBL] [Abstract][Full Text] [Related]
15. Management of end-stage liver disease in HIV/hepatitis C virus co-infection.
Spengler U
Curr Opin HIV AIDS; 2011 Nov; 6(6):527-33. PubMed ID: 21918437
[TBL] [Abstract][Full Text] [Related]
16. HIV/Hepatitis B and C co-infection: pathogenic interactions, natural history and therapy.
Chung RT; Kim AY; Polsky B
Antivir Chem Chemother; 2001; 12 Suppl 1():73-91. PubMed ID: 11594692
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function.
Padmapriyadarsini C; Chandrabose J; Victor L; Hanna LE; Arunkumar N; Swaminathan S
J Postgrad Med; 2006; 52(2):92-6. PubMed ID: 16679670
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana.
Sagoe KW; Agyei AA; Ziga F; Lartey M; Adiku TK; Seshi M; Arens MQ; Mingle JA
J Med Virol; 2012 Jan; 84(1):6-10. PubMed ID: 22095533
[TBL] [Abstract][Full Text] [Related]
19. Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in France.
de Monteynard LA; Dray-Spira R; de Truchis P; Grabar S; Launay O; Meynard JL; Khuong-Josses MA; Gilquin J; Rey D; Simon A; Pavie J; Mahamat A; Matheron S; Costagliola D; Abgrall S;
PLoS One; 2015; 10(3):e0118492. PubMed ID: 25734445
[TBL] [Abstract][Full Text] [Related]
20. Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection.
Cooper CL; Mills E
Int J STD AIDS; 2007 Aug; 18(8):546-50. PubMed ID: 17686217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
